BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Free Cash Flow Generation Index

Latest as of September 2025: 0.17x

BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Free Cash Flow Generation Index of 0.17x as of September 2025. Free cash flow of Rs25.78 Million represents 0% of operating cash flow (Rs149.66 Million). See BALAXI PHARMACEUTICALS LIMITED current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.17x
Free Cash Flow / Operating CF

Free Cash Flow

Rs25.78 Million
INR

Operating Cash Flow

Rs149.66 Million
INR

Capital Expenditures

Rs123.88 Million
INR

BALAXI PHARMACEUTICALS LIMITED Free Cash Flow Generation Index (2013–2024)

Historical FCF Generation Index trend for BALAXI PHARMACEUTICALS LIMITED across 6 annual periods. Explore BALAXI PHARMACEUTICALS LIMITED cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for BALAXI PHARMACEUTICALS LIMITED (2013–2024)

Year-by-year Free Cash Flow Generation Index for BALAXI PHARMACEUTICALS LIMITED. For the full company profile including market capitalisation, see how much is BALAXI PHARMACEUTICALS LIMITED worth.

Year FCG Index Free Cash Flow (INR) Operating CF Capital Expenditures YoY Change
2024 0.68x Rs32.97 Million Rs48.66 Million Rs15.69 Million ▲ +146.2%
2023 -1.47x Rs-89.05 Million Rs60.75 Million Rs149.80 Million ▼ -835.9%
2022 0.20x Rs68.00 Million Rs341.44 Million Rs273.44 Million ▲ +100.0%
2021 -823.61x Rs-25.53 Million Rs31.00K Rs25.56 Million ▼ -83636.6%
2015 0.99x Rs2.08 Million Rs2.11 Million Rs29.72K ▼ -1.4%
2013 1.00x Rs3.25 Million Rs3.25 Million Rs0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).